Another study using siRNA revealed that MerTK activated AKT and ERK in astrocytomas [51] and MerTK inhibitors decreased the phosphorylation of both AKT and ERK in GBM cell lines [41]. Here, AKT1 is linked to astrocytoma (excluding glioblastoma).